Back
Check Point Software Technologies Ltd. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
40
CHKP
Check Point Software Technologies Ltd.
Last Price:
$192.02
Seasonality Move:
10.24%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$68.42
Seasonality Move:
-31.39%
Sell
40
Check Point Software Technologies Ltd. (CHKP)
is a Sell
Is Check Point Software Technologies Ltd. a Buy, Sell or Hold?
-
The current Check Point Software Technologies Ltd. [CHKP] share price is $190.85. The Score for CHKP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
CHKP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHKP Stock Price Chart
What is Check Point Software Technologies Ltd.'s stock price today?
-
The Check Point Software Technologies Ltd. share price today is $190.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHKP is experiencing slight selling pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
CHKP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.26 | Sell |
| Relative Strength Index (14 RSI): | 48.59 | Sell |
| Chaikin Money Flow: | -118929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (186.24 - 198.46) | Sell |
| Bollinger Bands (100): | (186.3 - 205.16) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.48 | Buy |
| Relative Strength Index (14 RSI): | 86.01 | Buy |
| Chaikin Money Flow: | 124529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 42.89) | Buy |
| Bollinger Bands (100): | (18.11 - 33.75) | Buy |
CHKP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 189.53 | Buy |
| 20-day SMA: | 191.51 | Sell |
| 50-day SMA: | 194.89 | Sell |
| 200-day SMA: | 208.53 | Sell |
| 8-day EMA: | 190.61 | Buy |
| 20-day EMA: | 191.1 | Sell |
| 50-day EMA: | 193.79 | Sell |
| 200-day EMA: | 199.74 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.44 | Buy |
| 50-day SMA: | 32.1 | Buy |
| 200-day SMA: | 23.71 | Buy |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 32.59 | Buy |
| 200-day EMA: | 27.3 | Buy |
Check Point Software Technologies Ltd. Earnings Growth & CHKP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.18 per share, and a decrease next year of $0.71 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.
Check Point Software Technologies Ltd. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||